
Biosolutions: The time is now
This exclusive Capgemini survey reveals that 96% of organisations are already embracing the disruption of biosolutions
This exclusive Capgemini survey reveals that 96% of organisations are already embracing the disruption of biosolutions
Wireless charging has the potential to be the go-to power solution for implantable medical devices as technology innovation makes them smaller and smarter
It’s a key time for quantum technology and quantum computing; success awaits those who ensure quantum algorithms are purpose-built for business value creation
Cambridge Consultants is spearheading efforts to realise the clinical potential of omics through deep tech in digital microfluidics, photonics and quantum sensors
This is the year to put medtech investment to work. With macroeconomics improving, inflation easing and organizations stabilizing, now is the time to light the powder.
The first company to deploy cost-effective genomic measurements in mainstream medicine will not only transform healthcare, but also create lasting business value. But why has no-one cracked it yet?